Alternative to CPAP Machine

Alternative to CPAP machine options include oral appliance therapy, hypoglossal nerve stimulation, positional sleep therapy, surgical interventions, weight management programs, and emerging medication-based treatments. According to the American Academy of Sleep Medicine, CPAP remains the first-line treatment for obstructive sleep apnea, but research supports several evidence-based alternatives for patients who cannot tolerate continuous positive airway pressure therapy. This guide is for adults exploring non-CPAP treatment options due to mask discomfort, claustrophobia, travel needs, side effects, or long-term adherence challenges. Below, you will find a clinical comparison of every major CPAP alternative, including how each one works, who qualifies, the limitations involved, and how sleep apnea connects to biological aging through measurable biomarkers. If you suspect that untreated sleep apnea is accelerating your aging, the treatment path you choose matters more than most people realize.

Quick Answer

Alternatives to a CPAP machine include oral appliance therapy using mandibular advancement devices, hypoglossal nerve stimulation such as the Inspire implant, positional sleep therapy, upper airway surgery, weight loss interventions including GLP-1 receptor agonists, myofunctional therapy, and BiPAP or APAP devices. The right alternative depends on your apnea severity measured by apnea-hypopnea index, anatomy, BMI, and personal tolerance. Dumbo Health offers a $149 at-home sleep apnea test with physician diagnosis typically within 48 hours to help identify which treatment pathway fits your condition.

Key Takeaways

• Oral appliance therapy with mandibular advancement devices is the most widely recommended CPAP alternative for mild to moderate obstructive sleep apnea, with the American Academy of Sleep Medicine endorsing it as a first-line option for patients who decline CPAP
• Hypoglossal nerve stimulation (Inspire) reduces the apnea-hypopnea index by roughly 68% in appropriately selected patients, according to published clinical trial data
• Weight loss of 10% or more of body weight can reduce AHI scores significantly, and tirzepatide (Zepbound) is FDA-approved for moderate to severe obstructive sleep apnea in adults with obesity
• Untreated sleep apnea is associated with elevated inflammatory biomarkers such as hs-CRP and metabolic disruption that accelerate biological aging
• Dumbo Health's Core membership tracks 51 sleep-longevity biomarkers twice a year for $0.99 a day, giving members a way to measure how sleep apnea treatment is affecting their biological age over time
• A sleep physician should guide the choice between CPAP alternatives based on AHI severity, airway anatomy, oxygen desaturation index, and symptom burden rather than personal preference alone

Why People Look for Alternatives to CPAP Machines

CPAP therapy works, but roughly 30% to 50% of patients prescribed continuous positive airway pressure do not use it consistently within the first year, according to data referenced by the National Heart, Lung, and Blood Institute. The machine delivers a steady stream of air pressure through a CPAP mask to keep the airway open during sleep, preventing the repeated airway blockage that defines obstructive sleep apnea. For many people, the therapy eliminates snoring, reduces daytime drowsiness, and improves oxygen saturation overnight.

The problem is adherence. Claustrophobia from the face mask, nasal irritation, dry mouth from inadequate humidifier settings, noise from the hose, difficulty with pressure settings, skin irritation, and the inconvenience of traveling with a machine all drive patients away from CPAP machines over time.

Non-adherence is not a comfort issue alone. It is a longevity issue. When CPAP therapy is abandoned without a replacement treatment, the airway blockage, oxygen desaturation, and fragmented REM sleep continue. The downstream effects include elevated cortisol, disrupted metabolic patterns, increased cardiovascular strain, and measurable changes in biomarkers linked to biological aging.

DID YOU KNOW: The Wisconsin Sleep Cohort Study found that moderate to severe obstructive sleep apnea is significantly associated with increased mortality risk, and that many cases remain undiagnosed in the general population.

This is why choosing the right CPAP alternative matters clinically. It is not about swapping one device for another. It is about maintaining control over a sleep-related breathing disorder that, left untreated, accelerates aging at the cellular level. Dumbo Health's sleep longevity program tracks these aging biomarkers over time, giving you a measurable way to confirm that whatever treatment you choose is actually working.

KEY TAKEAWAY: CPAP machine intolerance is common and clinically significant because untreated sleep apnea drives biological aging through elevated inflammation, metabolic dysfunction, and cardiovascular stress markers.

Understanding the severity of your specific condition is the first step toward choosing the right alternative treatment.

Understanding Sleep Apnea Severity and Why It Shapes Your Options

The treatment modalities available to you depend almost entirely on how severe your sleep apnea is, as measured by the apnea-hypopnea index. AHI counts the number of times your airway partially or fully collapses per hour of sleep. The American Academy of Sleep Medicine classifies obstructive sleep apnea as mild (AHI 5 to 14), moderate (AHI 15 to 29), or severe (AHI 30 or higher).

Oxygen desaturation index, which measures how often blood oxygen drops by 3% or more per hour, adds another layer. A high ODI alongside a high AHI signals more physiologically dangerous apnea because the body is repeatedly starved of oxygen during sleep.

The Difference Between Obstructive and Central Sleep Apnea

Obstructive sleep apnea occurs when the soft tissues, tongue, and airway muscles relax during sleep and physically block airflow. Central sleep apnea occurs when the brain fails to send proper signals to the respiratory muscles. Some patients have a combination of both. Most CPAP alternatives target obstructive sleep apnea specifically because the problem is mechanical. Central sleep apnea typically requires different interventions and ongoing care from a sleep medicine specialist.

How Diagnosis Determines Which Alternatives You Qualify For

A sleep study, either in-lab polysomnography or an at-home sleep test, produces the AHI, ODI, and sleep pattern data that a sleep physician needs to recommend the right treatment. Without a diagnosis, you cannot access prescription oral appliances, qualify for hypoglossal nerve stimulation, or determine whether surgery is indicated.

Dumbo Health offers an FDA-cleared at-home sleep apnea test for $149, with physician diagnosis typically within 48 hours. The home sleep study uses a WatchPAT ONE device that tracks oxygen levels, heart rate, breathing-related signals, and body position over one night. The test is available in Florida, Texas, Virginia and Maryland. This data establishes whether you have mild, moderate, or severe obstructive sleep apnea and opens the door to the full range of treatment options discussed below.

Not every CPAP alternative is appropriate for every severity level. Oral appliance therapy is most effective for mild to moderate sleep apnea, while hypoglossal nerve stimulation and surgery are generally reserved for moderate to severe cases where other treatments have failed.

KEY TAKEAWAY: Your apnea-hypopnea index and oxygen desaturation index determine which alternatives to a CPAP machine are clinically appropriate, which is why a proper sleep study must come before any treatment decision.

With your severity level established, the next step is understanding each alternative in detail.

Oral Appliance Therapy: The Most Common CPAP Alternative

Oral appliance therapy is the most widely prescribed alternative to CPAP machines for patients with mild to moderate obstructive sleep apnea. These devices work by physically repositioning the lower jaw or tongue to keep the airway open during sleep.

Oral appliance therapy involves wearing a custom-fitted dental device during sleep that advances the mandible (lower jaw) forward, preventing the tongue and soft tissues from collapsing into the airway. The American Academy of Sleep Medicine recommends oral appliances as a first-line therapy for patients with mild to moderate obstructive sleep apnea who prefer them over CPAP, and as a second-line option for patients with severe OSA who cannot tolerate CPAP therapy.

Mandibular Advancement Devices

Mandibular advancement devices, also called MADs or oral advancement devices, are the most common type of oral appliance. A mandibular advancement device holds the lower jaw in a slightly forward position, which tightens the soft tissues around the airway and prevents collapse. MADs are custom-fitted by a dentist trained in sleep medicine and are adjustable to optimize the jaw position over time.

Research published on PubMed shows that mandibular advancement devices reduce AHI by roughly 50% on average, with better results in patients with mild to moderate OSA. They also significantly reduce snoring and improve sleep quality.

Tongue-Retaining Devices

A tongue-retaining device uses suction to hold the tongue forward during sleep, preventing it from falling back and blocking the airway. These are less commonly prescribed than MADs but may be used for patients who cannot wear a jaw-advancing appliance due to dental issues or temporomandibular joint problems.

What to Expect with an Oral Appliance

Most oral appliances require a prescription from a sleep physician or a doctor trained in dental sleep medicine. The device is custom-made from a mold of your teeth. Adjustment visits are typical over the first few months to dial in the right position. Side effects can include jaw soreness, excessive salivation, tooth discomfort, and minor bite changes over time.

Compared to a CPAP machine, oral appliances are quieter, more portable for travel, and easier to use. However, they are generally less effective than CPAP for severe obstructive sleep apnea, which is why severity-based guidance from a sleep specialist matters.

TIP: If you are considering oral appliance therapy, confirm your AHI through a sleep study first. Dumbo Health's $149 at-home sleep apnea test provides the diagnostic data a sleep physician needs to determine whether an oral appliance is appropriate for your severity level.

KEY TAKEAWAY: Mandibular advancement devices are the most evidence-backed CPAP alternative for mild to moderate obstructive sleep apnea, but they require a proper diagnosis, a prescription, and custom fitting to be effective.

For patients whose anatomy or severity requires something beyond an oral appliance, implantable nerve stimulation offers a different approach.

Hypoglossal Nerve Stimulation: The Inspire Implant

Hypoglossal nerve stimulation reduces the apnea-hypopnea index by stimulating the nerve that controls the tongue, preventing airway collapse during sleep without external devices or masks. The Inspire system is the most widely known hypoglossal nerve stimulation device approved by the U.S. Food and Drug Administration.

How Hypoglossal Nerve Stimulation Works

The Inspire device is surgically implanted during an outpatient procedure. A small pulse generator, placed under the skin in the upper chest, connects to a sensor near the ribs that detects breathing patterns and a stimulation lead placed on the hypoglossal nerve under the tongue. During sleep, the device senses each breath and delivers mild electrical stimulation to the tongue muscles, pushing the tongue forward and maintaining airflow through the upper airway.

The patient uses a small remote control to turn the device on before bed and off in the morning.

Clinical Results and Eligibility

Published data from the STAR trial, available on PubMed, showed that Inspire reduced median AHI from 29.3 to 9.0 events per hour at 12 months, representing approximately a 68% reduction. Five-year follow-up data confirmed sustained efficacy.

Eligibility criteria for Inspire implantation typically include:

• Moderate to severe obstructive sleep apnea (AHI between 15 and 65)
• Inability to tolerate or benefit from CPAP therapy
• BMI below 35 in most cases
• No concentric collapse of the airway (confirmed through drug-induced sleep endoscopy)
• Age 18 or older

Drug-induced sleep endoscopy is a procedure where a sleep specialist examines the airway while the patient is sedated to identify the specific pattern of airway collapse. Concentric collapse, where the airway closes in a circular pattern, predicts poor response to hypoglossal nerve stimulation.

Limitations of the Inspire Implant

Inspire requires surgery, which carries inherent risks including infection, tongue weakness, and device discomfort. Not all patients with moderate to severe OSA qualify. Insurance coverage varies, and out-of-pocket costs without insurance can be substantial. The device also requires periodic follow-up and battery replacement over time.

This is a treatment for patients who have clearly failed CPAP therapy and meet specific anatomical and severity criteria. It is not a first-line alternative for someone who simply finds CPAP inconvenient.

KEY TAKEAWAY: Hypoglossal nerve stimulation through the Inspire implant is a clinically proven option for moderate to severe obstructive sleep apnea when CPAP has failed, but eligibility depends on BMI, AHI range, and airway anatomy confirmed through drug-induced sleep endoscopy.

For patients who are not surgical candidates or who have milder apnea, positional therapy and weight management offer non-invasive alternatives.

Positional Therapy, Weight Loss, and Lifestyle Modifications

Positional sleep therapy and weight management are the most accessible and lowest-risk alternatives to a CPAP machine, particularly for patients with mild obstructive sleep apnea or position-dependent apnea.

Positional Sleep Therapy

Positional therapy works for patients whose apnea is significantly worse when sleeping on their back (supine position). In supine-dependent OSA, the tongue and soft tissues fall backward under gravity, worsening airway blockage. Positional sleep therapy uses wearable devices, specialized pillows, or vibrating alarms that train the patient to sleep on their side.

The Sleep Foundation notes that positional therapy can reduce AHI meaningfully in patients whose supine AHI is at least twice as high as their lateral AHI. Simple and inexpensive, it works best as a standalone treatment for mild cases or as a complement to other therapies.

Weight Loss and Its Effect on Sleep Apnea

Losing weight is one of the most effective non-device interventions for obstructive sleep apnea. Excess body weight, particularly fat deposits around the neck and airway, increases the mechanical load on the upper airway and contributes to collapse during sleep. The National Heart, Lung, and Blood Institute reports that weight loss of 10% to 15% of body weight can significantly reduce AHI in overweight and obese patients with OSA.

GLP-1 Receptor Agonists: Semaglutide and Liraglutide

Glucagon-like peptide 1 receptor agonists, including semaglutide and liraglutide, have generated significant interest as adjunct treatments for sleep apnea in obese patients. These medications, originally developed for type 2 diabetes and weight management, promote significant weight loss. Early clinical data suggests that GLP-1 receptor agonists may reduce AHI by decreasing the fat tissue compressing the upper airway. Tirzepatide (Zepbound), a GLP-1 and GIP receptor agonist, is FDA-approved for moderate to severe obstructive sleep apnea in adults with obesity. Semaglutide and liraglutide are not approved specifically for sleep apnea. None of these medications should be started, or used to replace CPAP, without a physician's guidance.

Lifestyle Changes That Support Airway Health

Beyond weight management, several lifestyle changes reduce symptoms and support airway function:

• Avoiding alcohol and sedatives before sleep, which relax airway muscles and worsen collapse
• Quitting smoking, which reduces airway inflammation and respiratory infections
• Managing nasal congestion from a deviated septum or allergies to improve airflow
• Maintaining consistent sleep-wake patterns to protect circadian rhythm and REM sleep quality

Lifestyle modifications alone are rarely sufficient to resolve moderate to severe obstructive sleep apnea. They are most effective as part of a combined approach with a device-based or surgical treatment, guided by a sleep physician.

KEY TAKEAWAY: Positional therapy and weight loss are evidence-based CPAP alternatives for mild or position-dependent sleep apnea, while tirzepatide (Zepbound) is FDA-approved for moderate to severe OSA in adults with obesity and should be used under physician care.

When non-invasive options are not enough, surgical interventions target the structural causes of airway obstruction.

Surgical Alternatives to CPAP Therapy

Upper airway surgery treats obstructive sleep apnea by physically modifying the structures that cause airway blockage. Surgery is generally reserved for patients who have failed both CPAP therapy and oral appliance therapy, or who have specific anatomical obstructions identified through drug-induced sleep endoscopy.

Uvulopalatopharyngoplasty

Uvulopalatopharyngoplasty, often abbreviated UPPP, removes excess tissue from the soft palate, uvula, and sometimes the tonsils to widen the airway. According to the American Academy of Sleep Medicine, UPPP is one of the most commonly performed surgeries for obstructive sleep apnea but has variable success rates depending on where the airway collapses. It is most effective when the obstruction is primarily at the palatal level.

Maxillomandibular Advancement

Maxillomandibular advancement is a more aggressive surgical option that moves both the upper and lower jaw forward, expanding the entire skeletal framework of the airway. This surgery is often reserved for patients with severe obstructive sleep apnea and significant craniofacial contribution to their airway obstruction. Published outcomes show AHI reductions of 80% or more in selected patients, but the procedure involves a longer recovery and higher surgical risk.

Tonsillectomy and Adenoidectomy

Tonsillectomy, the removal of enlarged tonsils, is particularly effective in patients whose tonsils physically narrow the airway. In adults, this is sometimes combined with UPPP. In children, tonsillectomy and adenoidectomy are often the first-line treatment for obstructive sleep apnea.

Barbed Reposition Pharyngoplasty

Barbed reposition pharyngoplasty is a newer technique that uses barbed sutures to reposition and tension the lateral pharyngeal wall muscles and soft tissues without removing tissue. Early data suggests it may improve outcomes compared to traditional UPPP in select patients by addressing lateral wall collapse.

Radiofrequency Thermotherapy

Radiofrequency thermotherapy, also called radiofrequency ablation, uses controlled thermal energy to shrink and stiffen soft tissues in the tongue base, soft palate, or turbinates. It is a less invasive outpatient procedure sometimes used for mild obstructive sleep apnea or snoring. Results are generally more modest than other surgical options.

Bariatric Surgery

Bariatric surgery addresses obstructive sleep apnea indirectly through substantial weight loss. For patients with a BMI of 35 or higher and comorbid OSA, Mayo Clinic notes that bariatric surgery can significantly reduce AHI and in some cases resolve sleep apnea entirely. However, not all patients achieve sufficient AHI reduction, and ongoing monitoring is necessary.

How to Compare Surgical Options

The following structured comparison highlights the key differences between the most common surgical interventions for obstructive sleep apnea.

Target Area

• Uvulopalatopharyngoplasty: Soft palate, uvula, tonsils
• Maxillomandibular Advancement: Upper and lower jaw, full skeletal airway
• Tonsillectomy: Tonsils (and adenoids in children)
• Hypoglossal Nerve Stimulation (Inspire): Tongue via nerve implant
• Bariatric Surgery: Body weight and fat distribution

Typical AHI Reduction

• Uvulopalatopharyngoplasty: Variable, roughly 30% to 50% depending on collapse site
• Maxillomandibular Advancement: Approximately 80% or more in selected patients
• Tonsillectomy: Highly effective when enlarged tonsils are the primary obstruction
• Hypoglossal Nerve Stimulation (Inspire): Approximately 68% based on STAR trial data
• Bariatric Surgery: Variable, dependent on degree of weight loss achieved

Best For

• Uvulopalatopharyngoplasty: Palatal-level obstruction, often combined with other procedures
• Maxillomandibular Advancement: Severe OSA with craniofacial contribution
• Tonsillectomy: Patients with visibly enlarged tonsils narrowing the airway
• Hypoglossal Nerve Stimulation (Inspire): Moderate to severe OSA, BMI under 35, non-concentric collapse
• Bariatric Surgery: BMI 35 or higher with comorbid obstructive sleep apnea

Recovery

• Uvulopalatopharyngoplasty: 2 to 3 weeks
• Maxillomandibular Advancement: 4 to 6 weeks
• Tonsillectomy: 1 to 2 weeks
• Hypoglossal Nerve Stimulation (Inspire): Days to weeks, outpatient procedure
• Bariatric Surgery: 2 to 6 weeks depending on procedure type

For most patients considering surgery, a sleep specialist will order drug-induced sleep endoscopy first to identify the specific airway collapse pattern and recommend the procedure most likely to succeed.

KEY TAKEAWAY: Surgical alternatives to CPAP are most effective when matched to the specific site of airway collapse identified through drug-induced sleep endoscopy, and they are typically reserved for patients who have failed non-surgical treatments.

Not all alternatives involve surgery or devices. Emerging therapies and breathing retraining approaches offer additional pathways.

Myofunctional Therapy, Oral Pressure Therapy, and Emerging Treatments

Myofunctional therapy and oral pressure therapy represent less invasive treatment modalities that target the muscles and pressures of the upper airway without surgery or traditional devices.

Myofunctional Therapy

Myofunctional therapy is a set of exercises that strengthen the tongue, soft palate, and airway muscles to reduce their tendency to collapse during sleep. A review published on PubMed found that oropharyngeal exercises reduced AHI by approximately 50% in adults with mild to moderate obstructive sleep apnea. The exercises, which typically include tongue positioning drills, cheek resistance exercises, and breathing retraining, must be performed consistently over weeks to months to produce results.

Myofunctional therapy is particularly relevant for patients with bruxism or poor tongue posture contributing to airway narrowing. It can be used as a standalone intervention for mild apnea or combined with oral appliance therapy or positional therapy for a complementary effect.

Oral Pressure Therapy and Negative Pressure Therapy

Oral pressure therapy, sometimes called negative pressure therapy or cNEP (continuous negative external pressure), applies a mild vacuum inside the oral cavity to pull the soft palate forward and stabilize the tongue, reducing airway collapse without a traditional positive airway pressure mask. These devices have shown some efficacy in clinical studies, but they are less widely available than MADs or CPAP and have more limited long-term outcome data.

BiPAP and APAP: Device-Based Alternatives Within the Positive Airway Pressure Family

BiPAP (bilevel positive airway pressure) and APAP (automatic positive airway pressure, sometimes called Auto-CPAP) are not alternatives to positive airway pressure in principle, but they address specific CPAP complaints.

• BiPAP delivers two different pressure levels: higher on inhalation and lower on exhalation. This is more comfortable for patients who struggle to exhale against the continuous pressure of a standard CPAP machine. BiPAP is also used for patients with central sleep apnea or complex sleep apnea where standard CPAP is insufficient.
• APAP automatically adjusts pressure throughout the night based on detected airflow obstruction, rather than delivering a fixed pressure setting. Many patients find APAP more comfortable because the machine delivers only the pressure needed at any given moment.

Both BiPAP and APAP still require a mask and a hose, so they do not eliminate the device-based complaints that drive some patients away from CPAP machines. However, they solve specific issues with pressure settings, comfort, and respiratory control.

Medications Under Investigation

Tirzepatide (Zepbound) is currently the only medication FDA-approved for obstructive sleep apnea, specifically for moderate to severe OSA in adults with obesity. Several other pharmacological approaches are under active investigation:

• Other GLP-1 receptor agonists (semaglutide, liraglutide) for weight-mediated AHI reduction
• Combination therapies targeting airway muscle tone during sleep
• Drugs addressing fluid redistribution from the legs to the neck during sleep, which worsens airway narrowing

The National Heart, Lung, and Blood Institute continues to fund research into medication-based sleep apnea treatments, and apart from tirzepatide for adults with obesity, pharmacological approaches remain adjunctive or investigational.

KEY TAKEAWAY: Myofunctional therapy is supported by clinical evidence for mild to moderate OSA and can be combined with other treatments, while BiPAP and APAP solve specific CPAP comfort issues without eliminating the mask and device entirely.

With so many alternatives available, a structured approach to choosing the right one is essential.

How to Choose the Right CPAP Alternative: A Step-by-Step Process

Choosing the right alternative to a CPAP machine requires a diagnosis, a clear understanding of your severity, and guidance from a qualified sleep physician or sleep medicine specialist.

Step-by-Step: Finding Your CPAP Alternative

1. Complete a sleep study to establish your AHI, ODI, and sleep patterns. Dumbo Health offers an FDA-cleared at-home sleep apnea test for $149 with physician diagnosis typically within 48 hours.
2. Review your results with a sleep physician who can explain whether your sleep apnea is mild, moderate, or severe and whether it is obstructive, central, or mixed.
3. Discuss why CPAP did not work for you. Claustrophobia, nasal irritation, mask fit issues, travel inconvenience, and side effects each point toward different alternatives.
4. Evaluate oral appliance therapy first if your AHI is mild to moderate. Request a referral to a dentist trained in dental sleep medicine for a custom mandibular advancement device.
5. Consider hypoglossal nerve stimulation or surgery if your AHI is moderate to severe and both CPAP and oral appliances have failed. Ask your sleep specialist about drug-induced sleep endoscopy to map your airway collapse pattern.
6. Incorporate lifestyle modifications regardless of which treatment you choose. Weight management, positional therapy, and myofunctional therapy can enhance the effectiveness of any primary treatment.
7. Track your treatment outcomes through biomarker testing. Dumbo Health's sleep longevity membership measures 51 sleep-longevity biomarkers twice a year, allowing you to see whether your treatment is reducing the inflammatory and metabolic markers associated with untreated sleep apnea.

After completing these steps, you will have a treatment plan tailored to your specific anatomy, severity, and lifestyle, rather than a one-size-fits-all device swap.

Checklist: Before Choosing a CPAP Alternative

• Confirm your sleep apnea diagnosis with a validated sleep study (polysomnography or at-home test)
• Know your AHI score and severity classification (mild, moderate, or severe)
• Know your ODI and any overnight oxygen desaturation patterns
• Understand whether your apnea is obstructive, central, or mixed
• Document why CPAP therapy did not work for you (specific symptoms and side effects)
• Ask your sleep physician about positional dependence in your sleep data
• Check your BMI, which affects eligibility for Inspire and guides weight-based interventions
• Review insurance coverage for alternatives such as oral appliances or surgery
• Consider Dumbo Health's Core membership to track biomarkers alongside treatment changes

Take the free quiz at Dumbo Health to understand your sleep health baseline.

KEY TAKEAWAY: The right CPAP alternative depends on your AHI severity, airway anatomy, BMI, and the specific reasons CPAP failed, which is why a structured diagnostic process must come before any treatment change.

Knowing the limitations of each approach helps you set realistic expectations.

Limitations, Risks, and When a CPAP Alternative May Not Work

No CPAP alternative works for every patient, and some carry risks that must be weighed against the benefits. Honest evaluation of limitations protects you from choosing a treatment that is unlikely to succeed.

Oral Appliances May Not Control Severe Sleep Apnea

Oral appliance therapy is most effective for mild to moderate obstructive sleep apnea. Patients with severe OSA (AHI above 30) often do not achieve adequate AHI reduction with mandibular advancement devices alone. The American Academy of Sleep Medicine recommends that patients with severe OSA who choose oral appliances over CPAP undergo follow-up sleep testing to verify treatment efficacy.

Surgery Carries Inherent Procedural Risk

Every surgical intervention, from uvulopalatopharyngoplasty to maxillomandibular advancement to Inspire implantation, carries risks including infection, bleeding, nerve damage, changes in voice or swallowing, and the possibility that the procedure does not adequately reduce AHI. Surgery is typically irreversible, and not all patients respond equally. Drug-induced sleep endoscopy helps predict surgical success, but no prediction is guaranteed.

Weight Loss Results Are Variable and Slow

While weight loss can significantly reduce AHI, the timeline is months to years, during which untreated or undertreated sleep apnea continues to affect your health. Not all patients with OSA are overweight, and not all overweight patients achieve sufficient weight loss to resolve their apnea. GLP-1 receptor agonists such as semaglutide accelerate weight loss but require ongoing use and carry their own side effect profiles, including gastrointestinal symptoms.

Positional Therapy Only Works for Position-Dependent Apnea

If your AHI is elevated in all sleep positions, positional therapy will not provide meaningful improvement. A sleep study that breaks down your AHI by position is necessary to determine whether this approach is relevant.

Myofunctional Therapy Requires Sustained Effort

Myofunctional therapy demands daily exercises over weeks to months. Compliance drops significantly over time, and the benefits are most pronounced in mild cases. It is best viewed as a complementary approach rather than a standalone treatment for anyone with moderate to severe OSA.

When CPAP Actually Is the Best Option

For patients with severe obstructive sleep apnea, high ODI values, significant daytime drowsiness, and cardiovascular risk, CPAP remains the most effective and most studied treatment. The alternatives described in this article exist for patients who genuinely cannot use CPAP, not for patients who simply have not tried troubleshooting their setup. Adjusting pressure settings, switching to a different CPAP mask style, adding a heated humidifier, or trying an APAP or BiPAP device can solve many common complaints without abandoning positive airway pressure entirely.

Dumbo Health's sleep apnea care, available in Florida, Texas, Virginia and Maryland, connects patients with a sleep physician who can help troubleshoot CPAP issues before recommending an alternative pathway.

KEY TAKEAWAY: Every CPAP alternative has specific limitations, and for severe obstructive sleep apnea with high oxygen desaturation, CPAP or BiPAP often remains the safest and most effective choice even when other options are available.

Real-world scenarios illustrate how these treatment decisions play out in practice.

Real-World Scenarios: Choosing the Right Treatment Path

Each patient's combination of severity, anatomy, lifestyle, and health goals points toward a different CPAP alternative. The following examples show how a sleep physician might approach common situations.

Scenario 1: A 38-Year-Old With Mild OSA and CPAP Claustrophobia

A 38-year-old woman is diagnosed with mild obstructive sleep apnea (AHI 11) after completing a home sleep study through Dumbo Health. She tried CPAP for three months but stopped because the face mask triggered claustrophobia and the nasal irritation disrupted her sleep further. Her BMI is 24, and she has no significant anatomical obstruction.

Her sleep physician recommends a custom mandibular advancement device as a first-line alternative. She also starts myofunctional therapy exercises to strengthen her tongue and airway muscles. At her six-month follow-up, her AHI drops to 4, and her snoring resolves. She adds Dumbo Health's Core membership to track whether her inflammatory markers, including hs-CRP, improve alongside her sleep quality.

Scenario 2: A 52-Year-Old Executive With Severe OSA and Travel Demands

A 52-year-old man with severe obstructive sleep apnea (AHI 42) and a BMI of 33 has used CPAP machines for five years. His adherence has been inconsistent because of frequent international travel. He experiences persistent daytime drowsiness, headaches, and moodiness despite partial CPAP use. He is concerned about cardiovascular risk given a family history of heart disease.

His sleep specialist orders drug-induced sleep endoscopy, which reveals anteroposterior tongue base collapse without concentric airway closure. He qualifies for Inspire implantation. After the outpatient procedure and activation, his AHI drops to 8. He no longer needs to travel with a CPAP machine. He enrolls in Dumbo Health's Concierge membership at $300 a month, which includes 103 biomarkers tested twice a year, a dedicated sleep physician with 24/7 access, and all add-on specialty packs including the Cardiac Strain panel to monitor NT-proBNP and high-sensitivity troponin alongside his treatment.

Scenario 3: A 45-Year-Old With Moderate OSA and a BMI of 38

A 45-year-old man with moderate obstructive sleep apnea (AHI 22) and a BMI of 38 cannot tolerate CPAP due to chronic nasal congestion from a deviated septum. His health care provider starts him on semaglutide for weight management while an ENT evaluates the deviated septum. After septoplasty resolves his nasal airway obstruction and his weight drops by 12%, a repeat sleep study shows his AHI has decreased to 9. He continues weight management and uses a positional sleep therapy device as a precautionary measure during sleep.

DID YOU KNOW: According to the CDC, more than 1 in 3 American adults are obese, which is one reason obstructive sleep apnea remains significantly underdiagnosed in the general population.

KEY TAKEAWAY: The best CPAP alternative varies by individual, depending on AHI severity, airway anatomy, BMI, lifestyle factors, and personal treatment goals, which is why personalized physician guidance is essential.

Understanding what these scenarios have in common reveals a broader theme: sleep apnea is not just a sleep problem. It is an aging problem.

Sleep Apnea, Biological Aging, and Why Biomarker Tracking Matters

Untreated obstructive sleep apnea accelerates biological aging through chronic intermittent hypoxia, systemic inflammation, and metabolic disruption. This connection is increasingly recognized in longevity medicine as one of the most actionable yet underaddressed drivers of premature aging.

How Sleep Apnea Accelerates Biological Age

Every time the airway collapses during sleep, the body experiences a burst of oxygen deprivation followed by a surge of stress hormones including cortisol. The National Institute on Aging explains that biological age can diverge meaningfully from chronological age, and chronic sleep disruption is one of the factors that drives that divergence.

Repeated oxygen desaturation elevates inflammatory markers such as hs-CRP. Fragmented sleep reduces growth hormone secretion, disrupts glucose metabolism (reflected in HbA1c levels), and increases cardiovascular strain markers. Over time, these effects compound, which is why untreated severe sleep apnea can make your biomarkers look older than your age.

Why Treatment Alone Is Not Enough Without Measurement

Choosing a CPAP alternative, whether an oral appliance, Inspire, surgery, or lifestyle modification, addresses the mechanical problem of airway blockage. But how do you know whether the downstream biological damage is actually reversing?

This is where biomarker tracking becomes essential. Dumbo Health's proprietary SleepLongevityAge metric combines blood biomarkers with optional wearable data from devices like Oura, Whoop, or Garmin to produce a single score that reflects how your sleep is affecting your biological age. The Core membership tests 51 sleep-longevity biomarkers twice a year for $0.99 a day (billed annually at $365 a year for early members), while the Concierge plan covers 103 biomarkers with a dedicated sleep physician and personal sleep coach.

SleepLongevityAge is a proprietary metric developed by Dumbo Health that estimates biological age based on sleep-relevant blood biomarkers and optional wearable device data. SleepLongevityAge provides a longitudinal measure of how effectively a treatment is reversing the biological damage caused by sleep apnea, giving both the patient and the physician objective data beyond AHI alone.

Blood draws are available at more than 2,000 Quest Diagnostics locations nationwide, with roughly 9 in 10 people living within 20 minutes of a testing location near you. In-home mobile phlebotomist draws are available in select states. All memberships are HSA and FSA eligible, require no insurance, no prior authorizations, and no surprise bills.

The Add-On Packs Most Relevant to Sleep Apnea Patients

For patients treating sleep apnea with any alternative to CPAP, several Dumbo Health add-on specialty packs are particularly relevant:

KEY TAKEAWAY: Treating sleep apnea addresses the airway, but tracking biomarkers through a program like Dumbo Health's sleep longevity membership reveals whether that treatment is actually reversing the biological aging caused by years of untreated apnea.

Separating widespread myths from clinical evidence helps you make a more informed decision.

Common Myths About CPAP Alternatives Debunked

MYTH: Over-the-counter mouthguards from a pharmacy work just as well as a prescription oral appliance for sleep apnea.

FACT: Over-the-counter mouthguards and boil-and-bite devices are not the same as custom-fitted mandibular advancement devices prescribed for obstructive sleep apnea. The American Academy of Sleep Medicine recommends only custom, titratable oral appliances made by a qualified dentist for OSA treatment. Generic mouthguards do not provide adequate jaw advancement, cannot be adjusted, and have not been validated in clinical studies for AHI reduction.

MYTH: If I stop snoring, my sleep apnea is gone and I do not need treatment.

FACT: Snoring is only one symptom of obstructive sleep apnea. You can have significant airway obstruction, oxygen desaturation, and fragmented sleep without audible snoring. The only way to confirm whether sleep apnea has resolved is through a follow-up sleep study measuring AHI and ODI. Some treatments reduce snoring without adequately reducing apnea events, which means the cardiovascular and metabolic risks persist.

MYTH: Sleep apnea only affects overweight people, so losing weight always cures it.

FACT: While obesity is the strongest modifiable risk factor for obstructive sleep apnea, the condition also occurs in people with a normal BMI due to craniofacial anatomy, enlarged tonsils, a deviated septum, or genetic factors affecting airway muscle tone. The NIH notes that approximately 20% to 40% of adults with OSA are not obese. Weight loss helps many patients but does not guarantee resolution, particularly when anatomical factors are the primary cause.

MYTH: CPAP alternatives are always more comfortable and easier to use than CPAP.

FACT: Each alternative has its own comfort trade-offs. Oral appliances can cause jaw pain, tooth shifting, and excessive drooling. Inspire requires surgery and has a recovery period. Positional therapy devices can be uncomfortable and may disrupt sleep initially. BiPAP and APAP still require a mask and hose. The best treatment is the one that adequately controls your AHI and that you can use consistently, which is different for every patient.

MYTH: You do not need to see a doctor to try a CPAP alternative.

FACT: Every evidence-based CPAP alternative requires either a prescription, a confirmed diagnosis, or both. Oral appliances require a prescription from a sleep physician or a referral to a dental sleep medicine specialist. Inspire requires surgical evaluation. Even positional therapy and weight management are most effective when guided by a health care provider who has reviewed your sleep study data. Attempting to self-treat sleep apnea without a diagnosis puts you at risk of undertreating a condition linked to cardiovascular disease, metabolic dysfunction, and accelerated biological aging.

KEY TAKEAWAY: Most misconceptions about CPAP alternatives stem from underestimating the clinical complexity of sleep apnea. A confirmed diagnosis, severity grading, and physician oversight are non-negotiable regardless of which treatment you choose.

Conclusion

The right alternative to a CPAP machine depends on your apnea severity, airway anatomy, body composition, and the specific reasons CPAP did not work for you. Oral appliance therapy, hypoglossal nerve stimulation, positional therapy, upper airway surgery, weight management, and emerging treatments like myofunctional therapy all have evidence behind them, but none of them are universally appropriate. A sleep study and physician guidance are the non-negotiable starting points.

What most people miss is that treating the airway is only half the equation. Untreated sleep apnea leaves a measurable biological footprint in your blood, and the only way to know whether your chosen treatment is reversing that damage is to track your biomarkers over time. Dumbo Health's free quiz is a good first step, and the Core membership at $0.99 a day gives you 51 sleep-longevity biomarkers tested twice a year, no insurance needed, HSA and FSA eligible, with early-member pricing locked for life.

Frequently Asked Questions About Alternatives to CPAP Machines

Can you treat sleep apnea without a CPAP machine?

Yes, sleep apnea can be treated without a CPAP machine in many cases, though the right alternative depends on the type and severity of your condition. Obstructive sleep apnea (OSA) is caused by the airway collapsing during sleep, and several non-CPAP approaches can help keep the airway open, including oral appliance therapy, positional therapy, hypoglossal nerve stimulation, and upper airway surgery. Lifestyle changes such as weight loss may also reduce apnea severity in some patients. A sleep physician should evaluate your apnea-hypopnea index and overall health before recommending any alternative to CPAP therapy.

Why would someone look for an alternative to a CPAP machine?

Many patients struggle with CPAP therapy due to mask discomfort, claustrophobia, nasal irritation, pressure settings that feel too strong, or difficulty sleeping with a hose attached to their face. Some people find the CPAP machine too disruptive for travel or for sleeping in certain positions. Side effects such as dry mouth, headaches, and bloating also lead patients to seek alternatives. According to the American Academy of Sleep Medicine, CPAP adherence is a known challenge, and clinicians frequently consider alternative treatment options for patients who cannot tolerate continuous positive airway pressure over the long term.

What is oral appliance therapy and how does it work as a CPAP alternative?

Oral appliance therapy uses a custom-fitted mouthguard-style device worn during sleep to keep the airway open. The most common type is a mandibular advancement device (MAD), which gently repositions the lower jaw forward to prevent the tongue and soft tissues at the back of the throat from collapsing and blocking the airway. Oral appliances are typically prescribed by a sleep physician or dentist trained in sleep medicine and require a prescription. They are a recognised alternative to CPAP for mild to moderate obstructive sleep apnea and for patients with severe OSA who cannot tolerate CPAP therapy.

What are mandibular advancement devices and are they effective for obstructive sleep apnea?

Mandibular advancement devices (MADs) are oral appliances that hold the lower jaw slightly forward during sleep, which helps keep the upper airway open and reduces breathing interruptions. They are one of the most widely studied CPAP alternatives for obstructive sleep apnea. The American Academy of Sleep Medicine recommends oral appliances as an appropriate treatment for patients with mild to moderate OSA and for patients with severe OSA who cannot use CPAP. Effectiveness varies by individual anatomy and apnea severity, and a sleep specialist should confirm whether a MAD is appropriate based on your diagnosis, apnea-hypopnea index, and airway structure.

What is hypoglossal nerve stimulation and when is it used?

Hypoglossal nerve stimulation is a surgical implant-based treatment for obstructive sleep apnea in which a small device is placed under the skin to monitor breathing patterns and deliver gentle electrical stimulation to the hypoglossal nerve, which controls tongue movement. The stimulation prevents the tongue from falling back and blocking the airway during sleep. The Inspire device is the best-known hypoglossal nerve stimulation system available in the United States. It is typically considered for patients with moderate to severe OSA who have not responded to CPAP therapy and who meet specific anatomical and clinical criteria. A sleep physician can assess whether implantation is appropriate.

What is positional therapy for sleep apnea?

Positional therapy is a treatment approach for patients whose obstructive sleep apnea occurs primarily or worsens when they sleep on their back. Sleeping in the supine position allows the tongue and soft tissues to fall toward the back of the throat more easily, increasing airway blockage. Positional sleep therapy involves using devices, pillows, or wearable aids to encourage side sleeping throughout the night. It is typically most effective for positional OSA, where the apnea-hypopnea index is significantly higher in the back-sleeping position than in the side-sleeping position. A sleep physician can confirm through a sleep study whether positional therapy is a suitable alternative to CPAP for your specific pattern of apnea.

What is myofunctional therapy and can it reduce sleep apnea?

Myofunctional therapy involves exercises that target the tongue, airway muscles, and surrounding soft tissues to improve muscle tone and reduce the tendency for the airway to collapse during sleep. The therapy typically involves a structured programme of mouth, tongue, and facial exercises performed daily over several weeks or months. Research suggests myofunctional therapy may reduce the apnea-hypopnea index in some patients with mild to moderate obstructive sleep apnea, though it is rarely used as a standalone treatment for severe OSA. It is sometimes recommended alongside other CPAP alternatives or as a supportive therapy. A sleep specialist or qualified myofunctional therapist can assess whether it is appropriate for your condition.

What is BiPAP and how does it differ from CPAP?

BiPAP stands for bilevel positive airway pressure. Unlike a standard CPAP machine, which delivers a single continuous air pressure throughout the night, a BiPAP machine uses two different pressure settings: a higher pressure during inhalation and a lower pressure during exhalation. This makes breathing feel more natural for some patients, particularly those who find exhaling against continuous positive airway pressure uncomfortable. BiPAP is sometimes prescribed when patients cannot tolerate standard CPAP settings or when they have conditions such as central sleep apnea, respiratory problems, or high pressure requirements. A sleep physician determines whether BiPAP is more appropriate than CPAP based on clinical evaluation and sleep study results.

What is APAP and how is it different from CPAP?

APAP stands for auto-adjusting positive airway pressure, sometimes called Auto-CPAP. Unlike a standard CPAP machine that delivers a fixed pressure throughout the night, an APAP device automatically adjusts its air pressure in real time based on your breathing patterns and detected airway events. This means the device delivers lower pressure when your airway is stable and increases pressure only when needed. Many patients find APAP more comfortable than fixed-pressure CPAP. APAP is typically prescribed for obstructive sleep apnea and is often the first device type recommended by sleep physicians. It is not generally appropriate for central sleep apnea or complex sleep-related breathing disorders.

What is oral pressure therapy and how does it differ from standard oral appliances?

Oral pressure therapy uses a device that fits inside the mouth and applies mild suction to help stabilise the soft palate and keep the airway open during sleep, rather than advancing the jaw forward like a mandibular advancement device. It is a less widely used alternative to CPAP and may suit patients who cannot tolerate jaw advancement devices due to bruxism, temporomandibular joint issues, or dental concerns. Oral pressure therapy is not appropriate for all types of obstructive sleep apnea, and evidence supporting its effectiveness is more limited than for mandibular advancement devices or hypoglossal nerve stimulation. A sleep physician should guide the decision about whether it is appropriate.

What is negative pressure therapy for sleep apnea?

Continuous negative external pressure therapy, sometimes abbreviated as cNEP, is a non-invasive alternative to CPAP that applies gentle suction to the front of the throat using a small collar-like device rather than delivering pressurised air through a mask. The negative pressure is intended to keep the upper airway open during sleep. cNEP is less widely available and has a smaller evidence base than CPAP, BiPAP, or oral appliance therapy. It may be considered for patients who cannot tolerate a CPAP mask. A sleep physician should evaluate whether negative pressure therapy is an appropriate option based on apnea severity, anatomy, and prior treatment history.

Can upper airway surgery treat sleep apnea instead of CPAP?

Yes, several surgical procedures can reduce or eliminate obstructive sleep apnea in appropriately selected patients. Uvulopalatopharyngoplasty (UPPP) removes or repositions excess soft tissue at the back of the throat to widen the airway. Maxillomandibular advancement surgery moves both the upper and lower jaw forward to create a larger airway space. Tonsillectomy may be appropriate when enlarged tonsils are contributing to airway obstruction. Barbed reposition pharyngoplasty is a more recent technique that repositions the lateral pharyngeal wall muscles to reduce airway collapse. The suitability of surgery depends on airway anatomy, OSA severity, and overall health. A sleep physician may recommend drug-induced sleep endoscopy to evaluate airway collapse patterns before recommending a specific surgical approach.

What lifestyle changes can help reduce sleep apnea severity without CPAP?

Several lifestyle changes can reduce the severity of obstructive sleep apnea, though they rarely eliminate it entirely in moderate or severe cases. Losing weight is one of the most clinically supported approaches, as excess weight contributes to narrowing of the upper airway. The National Heart, Lung, and Blood Institute notes that even modest weight loss can improve sleep-related breathing in some patients. Reducing alcohol consumption, particularly before bed, can help because alcohol relaxes airway muscles and increases the likelihood of obstruction. Treating nasal congestion, avoiding sedatives, and addressing a deviated septum may also improve airflow. These changes work best alongside, rather than instead of, medical treatment for diagnosed sleep apnea.

Can GLP-1 medications like semaglutide or liraglutide help with sleep apnea?

GLP-1 receptor agonists such as semaglutide and liraglutide are medications approved primarily for type 2 diabetes and obesity management that promote significant weight loss in many patients. Because excess body weight is a major risk factor for obstructive sleep apnea, meaningful weight reduction achieved with these medications may reduce apnea severity in some individuals. Clinical trials have shown improvements in the apnea-hypopnea index among patients with OSA who lost weight using semaglutide. However, GLP-1 medications are not approved as a direct treatment for sleep apnea, and whether they can replace CPAP therapy depends on individual response, weight loss achieved, and ongoing clinical evaluation. A healthcare provider should guide any decision about starting or continuing these medications in the context of sleep apnea care.

What is radiofrequency thermotherapy for sleep apnea?

Radiofrequency thermotherapy is a minimally invasive outpatient procedure used to reduce the volume of soft tissue in the upper airway, including the soft palate, tongue base, and lateral pharyngeal wall muscles. Heat energy is delivered through a small probe to shrink excess tissue and stiffen structures that may otherwise collapse during sleep. It is generally used for mild obstructive sleep apnea or for snoring, and it is less commonly used for moderate to severe OSA. Results vary between patients and multiple treatment sessions may be needed. A sleep physician should assess whether radiofrequency thermotherapy is appropriate based on airway anatomy and the severity of the sleep-related breathing disorder.

What travel-friendly alternatives to CPAP are available?

Travel is one of the most common reasons patients look for CPAP alternatives. For patients with mild to moderate obstructive sleep apnea, a mandibular advancement device is often the most practical travel option because it requires no power source, no hose, and no face mask. Some patients use positional therapy aids that are compact and lightweight. For those who still require positive airway pressure, travel-sized CPAP machines are smaller than standard devices and are compatible with international power supplies, though they still require a mask and power source. The right travel option depends on OSA severity and treatment response and should be discussed with a sleep physician before changing treatment routines during travel.

Is sleep apnea testing required before trying a CPAP alternative?

Yes, a diagnosis of sleep apnea should be established before starting any treatment, including CPAP alternatives. Without a sleep study, it is not possible to confirm whether sleep apnea is present, identify the type of apnea (obstructive versus central), or determine the apnea-hypopnea index, which guides treatment selection. Choosing an alternative to CPAP without a diagnosis risks undertreating or mistreating the condition, which can have serious health consequences including cardiovascular risk, daytime drowsiness, and impaired daytime function. A home sleep apnea test (HSAT) is a convenient first step for many patients with suspected obstructive sleep apnea. Dumbo Health offers a $149 at-home sleep apnea test with physician diagnosis typically within 48 hours.

What is an at-home sleep apnea test and how does it work?

A home sleep apnea test (HSAT) is an FDA-cleared device used to monitor breathing, oxygen saturation, airflow, and respiratory effort during sleep in the comfort of your own home. It is a simpler alternative to an in-lab polysomnography sleep study and is appropriate for most patients with suspected obstructive sleep apnea. The device is typically worn for one night and measures the apnea-hypopnea index and oxygen desaturation index, which a sleep physician uses to confirm a diagnosis. The American Academy of Sleep Medicine supports the use of home sleep testing for uncomplicated obstructive sleep apnea. Home sleep tests cannot reliably diagnose central sleep apnea or complex sleep disorders, for which in-lab polysomnography remains the standard.

When is an in-lab sleep study needed instead of a home sleep test?

An in-lab polysomnography sleep study is recommended when home sleep testing is insufficient to diagnose the suspected condition or when clinical complexity makes at-home monitoring inadequate. A sleep physician may recommend polysomnography when central sleep apnea, periodic limb movement disorder, narcolepsy, or another sleep disorder is suspected alongside obstructive sleep apnea. It is also preferred when a home sleep test result is negative but symptoms remain significant, when the patient has severe heart or lung disease, or when the clinical picture is unclear. A sleep specialist reviews the Epworth Sleepiness Scale score, symptom history, and risk factors to determine whether home testing is appropriate or whether an in-lab study is needed.

Can commercial drivers use alternatives to CPAP for DOT compliance?

Commercial drivers with obstructive sleep apnea who are required to comply with FMCSA sleep apnea guidelines must demonstrate adequate treatment and adherence, not simply any treatment preference. A certified medical examiner evaluates whether a driver's sleep apnea is being treated effectively and whether that treatment supports safe driving. CPAP therapy with documented adherence is the most commonly accepted treatment for commercial drivers. Some alternatives, such as oral appliance therapy with documented effectiveness confirmed through a follow-up sleep study, may be acceptable, but this depends on the certified medical examiner's assessment. Dumbo Health can support at-home sleep apnea testing for CDL drivers, but it does not make DOT certification decisions or guarantee medical clearance.

Does insurance cover CPAP alternatives like oral appliances or hypoglossal nerve stimulation?

Coverage for CPAP alternatives varies significantly by insurance plan, and many patients find that insurers require documented CPAP failure before authorising coverage for alternatives such as oral appliance therapy or hypoglossal nerve stimulation. The Centers for Medicare and Medicaid Services have specific criteria for coverage of oral appliances and implant devices like Inspire, generally requiring a confirmed diagnosis of moderate to severe OSA and evidence of CPAP intolerance. Prior authorisation requirements and out-of-pocket costs differ between plans. Patients who prefer transparent, cash-pay pricing without insurance complexity may find it useful to compare plans at Dumbo Health, where pricing is clear. Sleep apnea testing and CPAP care are available in Florida, Texas, Virginia and Maryland, and the Core and Concierge memberships are HSA and FSA eligible.

How does a sleep physician decide which CPAP alternative is right for a patient?

A sleep physician considers multiple factors when recommending a CPAP alternative, including the type of sleep apnea (obstructive versus central), the apnea-hypopnea index from a sleep study, the patient's anatomy, body weight, dental health, cardiovascular status, and the specific reasons CPAP therapy has not worked. The Epworth Sleepiness Scale is often used to assess daytime sleepiness. Drug-induced sleep endoscopy may be used to observe how the airway collapses during sleep before recommending surgery or implant-based therapy. There is no single best alternative to CPAP for all patients, and treatment decisions should be guided by a qualified sleep specialist based on individual diagnosis and clinical history. A healthcare professional can help determine whether testing or a specialist referral is the appropriate next step.

How does monitoring sleep biomarkers relate to sleep apnea treatment decisions?

Sleep apnea affects a wide range of physiological processes, including inflammation, cardiovascular function, hormonal balance, and metabolic health, all of which can be tracked through blood biomarkers. Elevated hs-CRP, for example, is associated with chronic low-grade inflammation that untreated sleep apnea can worsen. HbA1c may reflect metabolic disruption related to poor sleep quality and oxygen desaturation. Tracking biomarkers over time allows patients and clinicians to assess how well sleep apnea treatment, whether CPAP or an alternative, is affecting overall health. Dumbo Health's sleep longevity biomarker panel tests up to 103 markers covering metabolic, hormonal, inflammatory, and cardiovascular health, giving patients a data-backed view of how sleep is affecting biological aging.

What is the SleepLongevityAge score and how does it relate to sleep apnea?

SleepLongevityAge is Dumbo Health's proprietary metric that uses blood biomarker data and optional wearable data from devices such as Oura, Whoop, or Garmin to estimate how sleep may be affecting biological aging relative to chronological age. Untreated or poorly treated obstructive sleep apnea contributes to chronic inflammation, cardiovascular strain, metabolic dysfunction, and hormonal disruption, all of which can accelerate biological aging. The SleepLongevityAge score is a wellness and screening tool, not a medical diagnosis, and any abnormal biomarker results should be reviewed with a healthcare professional. Members can track their SleepLongevityAge over time to see how treatment decisions, including switching from CPAP to an alternative therapy, may be influencing their broader sleep health. Learn more at Dumbo Health's sleep longevity programme.

How much does it cost to get started with sleep apnea testing and care at Dumbo Health?

Dumbo Health offers an at-home sleep apnea test for a one-time fee of $149, which includes the FDA-cleared device and one night of testing, with physician diagnosis typically within 48 hours. This is priced separately from the longevity membership. The Core membership, which includes 51 sleep-longevity biomarkers tested twice a year and SleepLongevityAge tracking, starts at $0.99 a day for early members, billed annually at $365 a year. The Concierge membership, which includes 103 biomarkers, a dedicated sleep physician with 24/7 access, and a personal sleep coach, is $300 a month for early members, billed annually at $3,600 a year. All plans are cash-pay, HSA and FSA eligible, with no insurance required and no surprise bills.

When should someone see a doctor urgently about sleep apnea symptoms?

If you experience severe daytime drowsiness that affects your ability to drive or work safely, frequent gasping or choking during sleep witnessed by a partner, chest pain, irregular heartbeat, or significant mood changes and cognitive impairment, seek medical care promptly. Sleep apnea is associated with increased cardiovascular risk, and the National Heart, Lung, and Blood Institute recognises untreated obstructive sleep apnea as a significant contributor to high blood pressure, heart disease, and metabolic dysfunction. Snoring alone does not confirm sleep apnea, but persistent loud snoring with witnessed breathing pauses, morning headaches, and excessive daytime drowsiness warrants evaluation by a healthcare provider. The free quiz at Dumbo Health can help you decide whether at-home testing or a clinical referral is a useful starting point.